State Street’s Inhibikase Therapeutics IKT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $776K | Buy |
397,812
+355,928
| +850% | +$694K | ﹤0.01% | 3538 |
|
|
2025
Q1 | $91.7K | Hold |
41,884
| – | – | ﹤0.01% | 3988 |
|
|
2024
Q4 | $136K | Buy |
41,884
+31,800
| +315% | +$103K | ﹤0.01% | 3930 |
|
|
2024
Q3 | $13.1K | Hold |
10,084
| – | – | ﹤0.01% | 4251 |
|
|
2024
Q2 | $13.2K | Hold |
10,084
| – | – | ﹤0.01% | 4310 |
|
|
2024
Q1 | $21.8K | Hold |
10,084
| – | – | ﹤0.01% | 4285 |
|
|
2023
Q4 | $12.8K | Hold |
10,084
| – | – | ﹤0.01% | 4381 |
|
|
2023
Q3 | $14.2K | Buy |
10,084
+2
| +0% | +$3 | ﹤0.01% | 4476 |
|
|
2023
Q2 | $35.1K | Sell |
10,082
-1
| -0% | -$3 | ﹤0.01% | 4505 |
|
|
2023
Q1 | $39.8K | Hold |
10,083
| – | – | ﹤0.01% | 4556 |
|
|
2022
Q4 | $30.3K | Hold |
10,083
| – | – | ﹤0.01% | 4667 |
|
|
2022
Q3 | $55K | Hold |
10,083
| – | – | ﹤0.01% | 4633 |
|
|
2022
Q2 | $45K | Buy |
10,083
+400
| +4% | +$1.79K | ﹤0.01% | 4741 |
|
|
2022
Q1 | $86K | Buy |
9,683
+200
| +2% | +$1.78K | ﹤0.01% | 4685 |
|
|
2021
Q4 | $84K | Buy |
+9,483
| New | +$84K | ﹤0.01% | 4612 |
|